Author: Lynne Taylor

The European Parliament voted on October 23 to back a mutual recognition agreement for pharmaceuticals between the European Union (EU) and Israel, with 379 Members of the European Parliament (MEPs) voting in support of the agreement, 230 voting against it and 41 abstaining.

The regulator of NHS foundation trusts is urging them to start delivering hospital cost savings earlier in the year in order to reduce their exposure to financial risk.

The number of disease-modifying therapies (DMT) approved for the treatment of multiple sclerosis (MS) is expected to double to 2021, and this will intensify market fragmentation, according to new forecasts.

The European Union (EU) has reformed the rules for importing active pharmaceutical ingredients (APIs) for human-use medicines into Europe.

The European Parliament is due to vote on October 23 on a new accord which seeks to remove trade barriers between Israel and European Union (EU) member states for industrial products, starting with pharmaceuticals.